Loading…
Held by equity mutual funds in 14 disclosed months, Apr 2023 to May 2024.
Taro Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology) was held by 1 active equity mutual fund in May 2024, ₹31.9 Cr in all (up 0 funds from Apr 2024). The largest position was DSP Healthcare Fund at 1.4% of its portfolio. During the month 0 funds entered and 0 exited. Funds have disclosed holding it since Apr 2023.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
None.
None.
None.
How many equity funds held the company each month, and the value they held.